Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026571
Filing Date
2021-05-11
Accepted
2021-05-11 16:21:38
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-10q_20210331.htm   iXBRL 10-Q 2095649
2 EX-31.1 stsa-ex311_7.htm EX-31.1 21713
3 EX-31.2 stsa-ex312_9.htm EX-31.2 21471
4 EX-32.1 stsa-ex321_8.htm EX-32.1 9903
5 EX-32.2 stsa-ex322_6.htm EX-32.2 9827
  Complete submission text file 0001564590-21-026571.txt   6195614

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stsa-20210331.xsd EX-101.SCH 36802
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stsa-20210331_cal.xml EX-101.CAL 36403
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stsa-20210331_def.xml EX-101.DEF 98107
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20210331_lab.xml EX-101.LAB 296598
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20210331_pre.xml EX-101.PRE 209368
11 EXTRACTED XBRL INSTANCE DOCUMENT stsa-10q_20210331_htm.xml XML 1006141
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 21911615
SIC: 2834 Pharmaceutical Preparations